stockrowGlaukos Corporation (GKOS) vs Insulet Corporation (PODD)
- Glaukos Corporation GKOS 224.36 +1.99%
- Insulet Corporation PODD 145.23 −6.98%
Glaukos Corporation and Insulet Corporation are both Medical Devices companies. Glaukos Corporation is the larger, with a market value of $13.0B against $10.8B — 1.2× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Insulet Corporation trades at 25.2×. Glaukos Corporation grew revenue faster over the last twelve months: 46.9% against 26.5%. Insulet Corporation has the higher net margin (13.5% vs −24.6%) and the higher return on invested capital (18.8% vs −24.6%). Across the 20 metrics below, Insulet Corporation leads on 15 and Glaukos Corporation on 5.
Valuation
Profitability
| Metric | GKOS | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.13% | 71.88% | 57.76% |
| Operating margin | (25.52%) | 18.43% | (15.07%) |
| Net margin | (24.60%) | 13.45% | (14.45%) |
| Free cash flow margin | 5.22% | 8.15% | (3.88%) |
| Return on equity | (22.84%) | 28.94% | (10.35%) |
| Return on assets | (17.16%) | 13.31% | (17.26%) |
| Return on invested capital | (24.60%) | 18.77% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack